Hubei Goto Biopharm Co.,Ltd. (300966.SZ)
300966.SZ Stock Price Chart
Explore Hubei Goto Biopharm Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 300966.SZ price movements and trends.
300966.SZ Company Profile
Discover essential business fundamentals and corporate details for Hubei Goto Biopharm Co.,Ltd. (300966.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Apr 2021
Employees
631.00
Website
https://www.gotobiopharm.com/enCEO
Zubin Xi
Description
Hubei Goto Biopharm Co.,Ltd. engages in the production and sale of steroid hormone API's and intermediates in China. It offers starting materials, such as 9a-hydroxy-4-androstenedione(9a-OHAD), bisnoralcohol(BA), sitolactone, 1.4-androstadienedione(ADD), and 4-androstenedione(4-AD); intermediates, including estrogens, progesterone, nonsteroids, other hormones, and corticosteroids; and other pharmaceutical raw materials. The company was founded in 2006 and is based in Yicheng, China.
300966.SZ Financial Timeline
Browse a chronological timeline of Hubei Goto Biopharm Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 12 Jun 2024
A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 12 Jun 2024.
Dividend declared on 31 May 2022
A dividend of ¥0.14 per share was announced, adjusted to ¥0.14. The dividend was paid on 31 May 2022.
300966.SZ Stock Performance
Access detailed 300966.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.